RS RS Scientific logo
rsrsscientific.com
Health Care
Oncology Therapeutics
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
SFC Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
SFC Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Oncobox Diagnostics: Personalized Cancer Therapy via Transcriptomics. Explore our research, clinical efficacy, and company overview.
KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
Persevere Therapeutics novel drug is focused on improving effectiveness of cancer treatments.
SirnaMed is committed to developing innovative therapies that directly target the cause of cancer development, progression and treatment…
Overview
RS & RS Scientific leads in cutting-edge cancer therapy research, developing innovative therapies for challenging cancer treatments. Their expert team focuses on molecular breakthroughs to improve patient outcomes. Founded by Dr. Reza Salimi and Dr. Roghaiyeh Safari.